CHF1535 pMDI 50/6 µg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CHF1535 pMDI 50/6 µg, covering 2020-07-31 to 2020-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old [Phase 2]